The findings suggest that NT219's unique mechanism of degrading IRS1/2 and blocking downstream signaling pathways can potentially suppress metastasis and enhance chemotherapy effectiveness.

Treatment with PBA reversed the inhibition of IR signalling, as assessed by insulin-stimulated phospho-IRS1 (IR-substrate-1), IRS2 and phospho-AKT/PKB levels. Moreover, this treatment alleviated ...